Inventor · disambiguated record
Peiyuan Wang
Also filed as: WANG PEIYUAN
47 granted patents·10 pending applications·1,606 citations·filing 2003–2025
98Inventor score
Files withGILEAD SCIENCES INC26GILEAD PHARMASSET LLC17PHARMASSET INC3SOFIA MICHAEL JOSEPH3WANG PEIYUAN2
Top patents by PatentIndex Score
57 records- 0199US8906880B2Nucleoside phosphoramidate prodrugsGILEAD PHARMASSET LLC·Filed 2014·Granted Dec 9, 2014·65 cites·11 claims
- 0298US11642361B2Nucleoside phosphoramidate prodrugsGILEAD SCIENCES INC·Filed 2020·Granted May 9, 2023·4 cites·3 claims
- 0398US9085573B2Nucleoside phosphoramidate prodrugsGILEAD PHARMASSET LLC·Filed 2013·Granted Jul 21, 2015·54 cites·28 claims
- 0498US8957046B2Nucleoside phosphoramidate prodrugsGILEAD PHARMASSET LLC·Filed 2014·Granted Feb 17, 2015·51 cites·2 claims
- 0598US8642756B2Nucleoside phosphoramidatesROSS BRUCE·Filed 2010·Granted Feb 4, 2014·89 cites·23 claims
- 0698US8580765B2Nucleoside phosphoramidate prodrugsSOFIA MICHAEL JOSEPH·Filed 2012·Granted Nov 12, 2013·96 cites·14 claims
- 0798US8334270B2Nucleoside phosphoramidate prodrugsSOFIA MICHAEL JOSEPH·Filed 2011·Granted Dec 18, 2012·128 cites·25 claims
- 0898US7964580B2Nucleoside phosphoramidate prodrugsPHARMASSET INC·Filed 2008·Granted Jun 21, 2011·268 cites·14 claims
- 0998US7601820B2Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivativesPHARMASSET INC·Filed 2006·Granted Oct 13, 2009·88 cites·18 claims
- 1097US9284342B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2013·Granted Mar 15, 2016·23 cites·9 claims
- 1197US8735372B2Nucleoside phosphoramidate prodrugsGILEAD PHARMASSETT LLC·Filed 2013·Granted May 27, 2014·88 cites·2 claims
- 1297US8633309B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2013·Granted Jan 21, 2014·44 cites·12 claims
- 1397US8629263B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2013·Granted Jan 14, 2014·62 cites·25 claims
- 1497US8618076B2Nucleoside phosphoramidatesROSS BRUCE S·Filed 2011·Granted Dec 31, 2013·102 cites·36 claims
- 1596US11584738B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Feb 21, 2023·11 cites·47 claims
- 1696US8957045B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2013·Granted Feb 17, 2015·39 cites·20 claims
- 1796US8735569B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2013·Granted May 27, 2014·48 cites·6 claims
- 1896US8716262B2Nucleoside phosphoramidatesSOFIA MICHAEL JOSEPH·Filed 2009·Granted May 6, 2014·66 cites·36 claims
- 1996US8492539B2Preparation of 2′-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivativesCHUN BYOUNG-KWON·Filed 2005·Granted Jul 23, 2013·52 cites·7 claims
- 2096US7754699B2Antiviral nucleosidesROCHE PALO ALTO LLC·Filed 2006·Granted Jul 13, 2010·69 cites·16 claims
- 2195US11773122B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Oct 3, 2023·4 cites·38 claims
- 2295US9585906B2Nucleoside phosphoramidate prodrugsGILEAD PHARMASSET LLC·Filed 2015·Granted Mar 7, 2017·11 cites·10 claims
- 2395US8481713B2Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivativesWANG PEIYUAN·Filed 2010·Granted Jul 9, 2013·68 cites·4 claims
- 2494US11548871B2Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2020·Granted Jan 10, 2023·3 cites·30 claims
- 2593US10774071B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Sep 15, 2020·7 cites·18 claims
- 2693US9206217B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2013·Granted Dec 8, 2015·16 cites·4 claims
- 2792US12121529B2Nucleoside phosphoramidate prodrugsGILEAD SCIENCES INC·Filed 2023·Granted Oct 22, 2024·0 cites·29 claims
- 2891US10710986B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 14, 2020·4 cites·5 claims
- 2988US10040781B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2015·Granted Aug 7, 2018·3 cites·48 claims
- 3088US9637512B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2014·Granted May 2, 2017·3 cites·5 claims
- 3184US10183037B2Nucleoside phosphoramidate prodrugsGILEAD PHARMASSET LLC·Filed 2017·Granted Jan 22, 2019·2 cites·19 claims
- 3284US8093380B2Compounds with the bicyclo[4.2.1]nonane system for the treatment of Flaviviridae infectionsWANG PEIYUAN·Filed 2003·Granted Jan 10, 2012·33 cites·1 claims
- 3383US11555029B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Jan 17, 2023·1 cites·9 claims
- 3483US2025057867A1Nucleoside phosphoramidatesGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3582US12030904B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Jul 9, 2024·0 cites·18 claims
- 3681US10072001B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2015·Granted Sep 11, 2018·3 cites·30 claims
- 3778US2025270195A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 3877US12338233B2PD-1/Pd-L1 inhibitorsGILEAD SCIENCES INC·Filed 2022·Granted Jun 24, 2025·0 cites·4 claims
- 3977US11963967B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Apr 23, 2024·0 cites·51 claims
- 4077US10577359B2Preparation of 2′-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivativesGILEAD PHARMASSET LLC·Filed 2017·Granted Mar 3, 2020·1 cites·2 claims
- 4176US12473314B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Nov 18, 2025·0 cites·33 claims
- 4272US11999717B2Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Jun 4, 2024·0 cites·23 claims
- 4372US2025304554A1Lpa receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 4469US2010048917A1Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivativesPHARMASSETT INC·Filed 2009·Application pending·0 cites
- 4568US2018044367A1Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2017·Application pending·0 cites
- 4666US12208110B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Jan 28, 2025·0 cites·29 claims
- 4762US2016354400A1Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2016·Application pending·0 cites
- 4860US12269812B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Apr 8, 2025·0 cites·11 claims
- 4959US10253019B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2018·Granted Apr 9, 2019·0 cites·13 claims
- 5059US2013338349A1Preparation of 2'-fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivativesGILEAD PHARMASSET LLC·Filed 2013·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peiyuan Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →